Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Yumanity Therapeutics Inc (YMTX)

Yumanity Therapeutics Inc (YMTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Yumanity Therapeutics Inc 40 GUEST STREET SUITE 4410 BOSTON MA 02135 USA

www.yumanity.com P: 617-409-5300

Description:

Yumanity Therapeutics Inc. is a clinical-stage biopharmaceutical company involved in the treatment of neurodegenerative diseases. The company's product candidate includes YTX-7739.Yumanity Therapeutics Inc., formerly known as Proteostasis Therapeutics Inc., is based in BOSTON.

Key Statistics

Overview:

Market Capitalization, $K 20,518
Enterprise Value, $K -2,812
Shares Outstanding, K 10,856
Annual Sales, $ 8,040 K
Annual Net Income, $ -39,500 K
Last Quarter Sales, $ 1,400 K
Last Quarter Net Income, $ -3,360 K
60-Month Beta 0.32
% of Insider Shareholders 12.45%
% of Institutional Shareholders 25.10%
Float, K 9,504
% Float 87.55%
Short Volume Ratio 0.45

Growth:

1-Year Return -39.42%
3-Year Return -92.41%
5-Year Return -98.35%
5-Year Revenue Growth -4.06%
5-Year Earnings Growth 90.68%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.31 on 11/14/22
Next Earnings Date 11/21/22
Earnings Per Share ttm -3.00
EPS Growth vs. Prev Qtr 31.11%
EPS Growth vs. Prev Year 68.04%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-7 on 12/19/22

YMTX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -263.34%
Return-on-Assets % -107.08%
Profit Margin % -491.29%
Debt/Equity 0.00
Price/Sales 2.35
Price/Cash Flow N/A
Price/Book 3.75
Book Value/Share 0.50
Interest Coverage -20.70
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar